Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 2
2016 2
2017 3
2018 2
2019 2
2020 1
2021 2
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Memory Consolidation during Ultra-short Offline States.
Wamsley EJ, Arora M, Gibson H, Powell P, Collins M. Wamsley EJ, et al. Among authors: gibson h. J Cogn Neurosci. 2023 Oct 1;35(10):1617-1634. doi: 10.1162/jocn_a_02035. J Cogn Neurosci. 2023. PMID: 37584585
Grambank reveals the importance of genealogical constraints on linguistic diversity and highlights the impact of language loss.
Skirgård H, Haynie HJ, Blasi DE, Hammarström H, Collins J, Latarche JJ, Lesage J, Weber T, Witzlack-Makarevich A, Passmore S, Chira A, Maurits L, Dinnage R, Dunn M, Reesink G, Singer R, Bowern C, Epps P, Hill J, Vesakoski O, Robbeets M, Abbas NK, Auer D, Bakker NA, Barbos G, Borges RD, Danielsen S, Dorenbusch L, Dorn E, Elliott J, Falcone G, Fischer J, Ghanggo Ate Y, Gibson H, Göbel HP, Goodall JA, Gruner V, Harvey A, Hayes R, Heer L, Herrera Miranda RE, Hübler N, Huntington-Rainey B, Ivani JK, Johns M, Just E, Kashima E, Kipf C, Klingenberg JV, König N, Koti A, Kowalik RGA, Krasnoukhova O, Lindvall NLM, Lorenzen M, Lutzenberger H, Martins TRA, Mata German C, van der Meer S, Montoya Samamé J, Müller M, Muradoglu S, Neely K, Nickel J, Norvik M, Oluoch CA, Peacock J, Pearey IOC, Peck N, Petit S, Pieper S, Poblete M, Prestipino D, Raabe L, Raja A, Reimringer J, Rey SC, Rizaew J, Ruppert E, Salmon KK, Sammet J, Schembri R, Schlabbach L, Schmidt FWP, Skilton A, Smith WD, de Sousa H, Sverredal K, Valle D, Vera J, Voß J, Witte T, Wu H, Yam S, Ye J, Yong M, Yuditha T, Zariquiey R, Forkel R, Evans N, Levinson SC, Haspelmath M, Greenhill SJ, Atkinson QD, Gray RD. Skirgård H, et al. Among authors: gibson h. Sci Adv. 2023 Apr 21;9(16):eadg6175. doi: 10.1126/sciadv.adg6175. Epub 2023 Apr 19. Sci Adv. 2023. PMID: 37075104 Free PMC article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, Wellington E, Khawam J, Munro K, Cole M, Tranquillini C, Taylor-Kerr A, Hettiarachchi N, Calbraith D, Sajedi N, Milligan I, Themistocleous Y, Corrigan D, Cromey L, Price L, Stewart S, de Lacy E, Norman C, Linley E, Otter AD, Semper A, Hewson J, D'Arcangelo S, Chand M, Brown CS, Brooks T, Islam J, Charlett A, Hopkins S; SIREN Study Group. Hall V, et al. N Engl J Med. 2022 Mar 31;386(13):1207-1220. doi: 10.1056/NEJMoa2118691. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172051 Free PMC article.
Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.
Tran DL, Gibson H, Maiorana AJ, Verrall CE, Baker DW, Clode M, Lubans DR, Zannino D, Bullock A, Ferrie S, Briody J, Simm P, Wijesekera V, D'Almeida M, Gosbell SE, Davis GM, Weintraub R, Keech AC, Puranik R, Ugander M, Justo R, Zentner D, Majumdar A, Grigg L, Coombes JS, d'Udekem Y, Morris NR, Ayer J, Celermajer DS, Cordina R. Tran DL, et al. Among authors: gibson h. Front Pediatr. 2022 Jan 6;9:799125. doi: 10.3389/fped.2021.799125. eCollection 2021. Front Pediatr. 2022. PMID: 35071139 Free PMC article. Review.
23 results